Erratum: Focal segmental glomerulosclerosis(Clin J Am Soc Nephrol (2017),12,502-517, 10.2215/CJN.05960616)

Avi Z. Rosenberg, Jeffrey B. Kopp

Research output: Contribution to journalComment/debatepeer-review


Due to author error, a correction has been issued for the above referenced article. The following sentence inaccurately spells out suPAR. The text should have read “soluble urokinase-type plasminogen activator receptor” instead of “serum urine–type plasminogen activator receptor”. The authors regret any confusion this may have caused to readers. “Current candidates for the recurrent FSGS factor, reviewed recently (44), include cardiotrophin like cytokine factor 1 (45), apoA1b (an isoform of ApoA1) (46), anti-CD40 antibody (47), and serum urine–type plasminogen activator receptor (suPAR) (48).”.

Original languageEnglish (US)
Pages (from-to)1889
Number of pages1
JournalClinical Journal of the American Society of Nephrology
Issue number12
StatePublished - Dec 7 2018

ASJC Scopus subject areas

  • Epidemiology
  • Critical Care and Intensive Care Medicine
  • Nephrology
  • Transplantation


Dive into the research topics of 'Erratum: Focal segmental glomerulosclerosis(Clin J Am Soc Nephrol (2017),12,502-517, 10.2215/CJN.05960616)'. Together they form a unique fingerprint.

Cite this